Line 1: |
Line 1: |
− | * Renal excretion. Acts on COX 1/2. Inhibits renal production of prostaglandins. | + | * e.g. Ibuprofen, Naproxen, Ketorolac |
− | * Safe for short term use in patients with stage 1-2 CKD. Risk of causing AKI is same as in general population. No evidence that it will increase risk of progression. | + | * Renally excreted. Acts on COX 1/2. Inhibits renal production of prostaglandins. |
| + | * Safe for short term use in patients with stage 1-2 [[CKD]]. Risk of causing [[AKI]] is same as in general population. No evidence that it will increase risk of progression. |
| + | * Schedule NSAIDs, if they are only PRNs they likely won’t happen. |
| + | * Topical = Diclofenac gel (Voltaren). |